(Q39276829)

10 September 2017

1 reference

reason for preferred rank

title

The substituted benzamides - a novel class of dopamine antagonists (English)

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90559-9

3 November 2022

The substituted benzamides--a novel class of dopamine antagonists (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A40086

3 November 2022

0 references

2

Marsden CD

1 reference

10 September 2017

P. Jenner

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A40086

3 November 2022

C. D. Marsden

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A40086

3 November 2022

language of work or name

English

0 references

publication date

1 August 1979

1 reference

10 September 2017

6 August 1979

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=40086

full work available at URL

3 November 2022

https://api.elsevier.com/content/article/PII:0024320579905599?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90559-9

https://api.elsevier.com/content/article/PII:0024320579905599?httpAccept=text/plain

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90559-9

3 November 2022

1 reference

10 September 2017

volume

25

1 reference

10 September 2017

issue

6

1 reference

10 September 2017

page(s)

479-485

1 reference

EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN.

10 September 2017

cites work

3

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90559-9

3 November 2022

Q64864197

9

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90559-9

Effect of sulpiride on serum prolactin levels in humans

3 November 2022

11

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90559-9

Metoclopramide stimulates prolactin secretion in man.

3 November 2022

12

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90559-9

Dystonic reactions in children caused by metoclopramide

3 November 2022

14

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90559-9

Extrapyramidal side-effects of metoclopramide

3 November 2022

17

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90559-9

Effects of the administration of two doses of sulpiride on the behaviour of the rat

3 November 2022

19

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90559-9

Effects of N-(ethyl-2 pyrrolidinyl-methyl)-2-methoxy-5-sulfamoil-benzamide (sulpyrid) on the central nervous system in rats and mice

3 November 2022

20

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90559-9

Substituted benzamides as cerebral dopamine antagonists in rodents

3 November 2022

22

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90559-9

A comparison of the abilities of typical neuroleptic agents and of thioridazine, clozapine, sulpiride and metoclopramide to antagonise the hyperactivity induced by dopamine applied intracerebrally to areas of the extrapyramidal and mesolimbic systems

3 November 2022

23

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90559-9

Antagonism of the hyperactivity induced by dopamine applied intracerebrally to the nucleus accumbens septi by typical neuroleptics and by clozapine, sulpiride and thioridazine

3 November 2022

24

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90559-9

Climbing behavior induced by apomorphine in mice: a simple test for the study of dopamine receptors in striatum

3 November 2022

25

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90559-9

Antagonism by sulpiride of three apomorphine-induced effects in rodents

3 November 2022

26

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90559-9

Climbing behaviour induced by apomorphine in mice: A potential model for the detection of neuroleptic activity

3 November 2022

27

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90559-9

Inhibition of circling behavior by neuroleptic drugs in mice with unilateral 6-hydroxydopamine lesions of the striatum

3 November 2022

28

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90559-9

A comparison of in vitro and in vivo dopamine receptor antagonism produced by substituted benzamide drugs

3 November 2022

30

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90559-9

Inhibition of the apomorphine gnawing compulsion by amantadine

3 November 2022

31

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90559-9

Detection of the neuroleptic properties of clozapine, sulpiride and thioridazine

3 November 2022

32

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90559-9

Differential effect of neuroleptic drugs on dopamine turnover in the extrapyramidal and limbic system

3 November 2022

34

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90559-9

Increase of brain homovanillic acid level induced by metoclopramide

3 November 2022

35

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90559-9

Effect of metoclopramide on turnover of brain dopamine noradrenaline and 5-hydroxytryptamine

3 November 2022

36

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90559-9

Regional effects of neuroleptics of dopamine metabolism and dopamine-sensitive adenylate cyclase activity

3 November 2022

39

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90559-9

On the relevance of preferential increases of mesolimbic versus striatal dopamine turnover for the prediction of antipsychotic activity of psychotropic drugs

3 November 2022

41

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90559-9

Regional rat brain levels of 3,4-dihydroxyphenylacetic acid and homovanillic acid: concurrent fluorometric measurement and influence of drugs

3 November 2022

42

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90559-9

On the significance of regional dopamine metabolism in the rat brain for the classification of centrally acting drugs.

3 November 2022

43

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90559-9

Metoclopramide and dopamine receptor blockade.

3 November 2022

44

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90559-9

Antipsychotic drug doses and neuroleptic/dopamine receptors

3 November 2022

45

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90559-9

Anti-schizophrenic drugs—Membrane receptor sites of action

3 November 2022

47

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90559-9

Specificity of the dopamine sensitive adenylate cyclase for antipsychotic antagonists

3 November 2022

48

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90559-9

Sulpiride: A study of the effects on dopamine receptors in rat neostriatum and limbic forebrain

3 November 2022

49

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90559-9

Peripheral and central muscarinic receptor affinity of psychotropic drugs

3 November 2022

50

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90559-9

The noradrenergic cyclic AMP generating system in the limbic forebrain: Pharmacological characterization in vitro and possible role of limbic noradrenergic mechanisms in the mode of action of antipsychotics

3 November 2022

52

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90559-9

Inhibition by apomorphine of the metoclopramide-induced catalepsy and increase in striatal homovanillic acid content

3 November 2022

55

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90559-9

Atropine manipulation of elevated cerebral dopamine turnover caused by haloperidol or substituted benzamide drugs

3 November 2022

56

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90559-9

Assessment of the neuroleptic potential of some novel benzamide, butyrophenone, phenothiazine and indole derivatives

3 November 2022

57

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90559-9

Evidence for dopamine receptors mediating sedation in the mouse brain

3 November 2022

58

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90559-9

Effect of substituted benzamide drugs on rat striatal tyrosine hydroxylase

3 November 2022

59

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90559-9

Affinities of drugs for the agonist and antagonist states of the dopamine receptor

3 November 2022

60

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90559-9

Dopamine receptor binding: specificity, localization and regulation by ions and guanyl nucleotides

3 November 2022

61

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90559-9

Excitation-mediating and inhibition-mediating dopamine-receptors: A new concept towards a better understanding of electrophysiological, biochemical, pharmacological, functional and clinical data

3 November 2022

62

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90559-9

Neuroleptic antagonism of dyskinetic phenomena

3 November 2022

63

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90559-9

Two binding sites for 3H-spiroperidol on rat striatal membranes

3 November 2022

64

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90559-9

Differential distribution of opiate and neuroleptic receptors and dopamine-sensitive adenylate cyclase in rat brain

3 November 2022

66

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90559-9

Multiple classes of dopamine receptors in mammalian central nervous system: The involvement of dopamine-sensitive adenylyl cyclase

3 November 2022

67

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90559-9

Dopamine receptors localised on cerebral cortical afferents to rat corpus striatum

3 November 2022

68

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90559-9

gamma-Aminobutyric acid-stimulated chloride permeability in crayfish muscle

3 November 2022

69

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90559-9

Interaction of barbiturates with dihydropicrotoxinin binding sites related to the GABA receptor-ionophore system

3 November 2022

71

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90559-9

Dopamine receptor blocking activity of sulpiride in the central nervous system

3 November 2022

72

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90559-9

Differential activities of some benzamide derivatives on peripheral and intracerebral administration

3 November 2022

73

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90559-9

3 November 2022

Identifiers

1 reference

10 September 2017

1 reference